Press Releases :: Aurinia Pharmaceuticals Inc. (AUPH)

December 28, 2016 • 5:56 pm EST

Aurinia Closes US$28 Million Financing

December 22, 2016 • 6:00 am EST

Aurinia Announces US$25.0 Million Bought Deal Financing

December 19, 2016 • 4:05 pm EST

Aurinia Announces Long-Term Manufacturing Collaboration Agreement with Lonza for Clinical and Commercial Supply of Voclosporin

December 13, 2016 • 8:00 am EST

Aurinia Confirms Receipt of FDA End of Phase 2 Meeting Minutes

December 12, 2016 • 4:05 pm EST

Aurinia Announces Appointment of Biotech Industry Leader Jeffry Randall to its Board of Directors and Audit Committee

November 21, 2016 • 9:27 am EST

Aurinia Highlights Renal Function Data from Global Phase IIb AURA Study of Voclosporin for Lupus Nephritis at American Society of Nephrology Kidney Week 2016

November 16, 2016 • 8:00 am EST

Aurinia Highlights Speed of Remission from Global Phase IIb AURA Study of Voclosporin in Lupus Nephritis at 2016 American College of Rheumatology Annual Meeting

November 10, 2016 • 1:35 pm EST

Aurinia Pharmaceuticals to Present at Stifel 2016 Healthcare Conference

November 9, 2016 • 5:05 pm EST

Aurinia Establishes At-The-Market Facility

November 4, 2016 • 6:55 pm EDT

Aurinia Reports Third Quarter 2016 Financial Results and Operational Highlights

Select a page:

rss_feed News RSS

©2025 Aurinia Pharmaceuticals Inc. All Rights Reserved. US-LUP-2300105 08/23